BOT:ASX
Botanix Pharmaceuticals Ltd
A$0.022
0.00%
(0.00) 1D
Jun 4, 1:29:07 PM GMT+10 · AUD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
A$0.02
High
A$0.02
Low
A$0.02
Mkt. cap
63.16M
Avg. vol.
20.92M
Volume
3.11M
52-wk high
A$0.36
52-wk low
A$0.02
EPS
-A$0.05
Shares outstanding
2.73B
No. of employees
11
Open
A$0.02
High
A$0.02
Low
A$0.02
Mkt. cap
63.16M
Avg. vol.
20.92M
Volume
3.11M
52-wk high
A$0.36
52-wk low
A$0.02
EPS
-A$0.05
Shares outstanding
2.73B
No. of employees
11
News stories
From sources across the web
NBC4 WCMH-TV
·
26 minutes ago
Asian shares retreat as US stocks halt their record-breaking rally, while oil prices fall back
Simply Wall Street
·
10 minutes ago
Assessing Atlassian (NasdaqGS:TEAM) Valuation After An AI And Cloud Fueled Earnings Beat
The Globe and Mail
·
29 minutes ago
The S&P 500 Index Has Only Traded at This High a Valuation 1 Other Time in Its 69-Year Existence. History Couldn't Be Any Clearer on What Happens Next.
Investor's Business Daily
·
40 minutes ago
Futures: SpaceX Sets IPO Price Target; Two AI Giants Dive Late
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
AI content may include mistakes. Learn more